rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-29
|
pubmed:abstractText |
The EGFR [epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)] gene is known to harbor genomic alterations in advanced lung cancer involving gene amplification and kinase mutations that predict the clinical response to EGFR-targeted inhibitors. Methods for detecting such molecular changes in lung cancer tumors are desirable.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1530-8561
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
623-32
|
pubmed:meshHeading |
pubmed-meshheading:20207772-Adult,
pubmed-meshheading:20207772-Aged,
pubmed-meshheading:20207772-Aged, 80 and over,
pubmed-meshheading:20207772-Alleles,
pubmed-meshheading:20207772-DNA, Neoplasm,
pubmed-meshheading:20207772-DNA Mutational Analysis,
pubmed-meshheading:20207772-Disease Progression,
pubmed-meshheading:20207772-Female,
pubmed-meshheading:20207772-Genome, Human,
pubmed-meshheading:20207772-Genotype,
pubmed-meshheading:20207772-Humans,
pubmed-meshheading:20207772-Lung Neoplasms,
pubmed-meshheading:20207772-Male,
pubmed-meshheading:20207772-Middle Aged,
pubmed-meshheading:20207772-Mutation,
pubmed-meshheading:20207772-Neoplasm Staging,
pubmed-meshheading:20207772-Polymerase Chain Reaction,
pubmed-meshheading:20207772-Predictive Value of Tests,
pubmed-meshheading:20207772-Receptor, Epidermal Growth Factor,
pubmed-meshheading:20207772-Tumor Cells, Cultured
|
pubmed:year |
2010
|
pubmed:articleTitle |
Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays.
|
pubmed:affiliation |
Fluidigm Corporation, South San Francisco, CA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|